Publicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (10)

2023

  1. Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease

    Cells, Vol. 12, Núm. 5

2022

  1. The parkinsonian LRRK2 R1441G mutation shows macroautophagy-mitophagy dysregulation concomitant with endoplasmic reticulum stress

    Cell Biology and Toxicology, Vol. 38, Núm. 5, pp. 889-911

2020

  1. Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease

    Aging, Vol. 12, Núm. 17, pp. 16690-16708

2019

  1. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation: Mechanistic insights and clinical implications

    Hypertension, Vol. 73, Núm. 3, pp. 602-611

  2. Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson’s Disease Patients

    Molecular Neurobiology, Vol. 56, Núm. 4, pp. 2466-2481

2018

  1. Acetylome in human fibroblasts from Parkinson’s disease patients

    Frontiers in Cellular Neuroscience, Vol. 12

2016

  1. Pompe disease and autophagy: Partners in crime, or cause and consequence?

    Current Medicinal Chemistry, Vol. 23, Núm. 21, pp. 2275-2285

2014

  1. G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy

    Toxicology, Vol. 324, pp. 1-9

2013

  1. The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway

    Cellular and Molecular Life Sciences, Vol. 70, Núm. 1, pp. 121-136

2012

  1. The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts

    Autophagy, Vol. 8, Núm. 10, pp. 1537-1539